Delivery Order SPE2DB20D2104-SPE2DB25FMLXQ
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,175.96, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat respiratory conditions. The contract has a completion date of March 17, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) the vendor holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a total ceiling value of $2,503.80 and an ultimate completion date of January 7, 2025. The contract is a firm-fixed-price delivery order, with no...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $11,831.94 firm fixed-price contract is for the delivery of Trelegy Ellipta 100-62.5-25 medication, a combination drug product used to treat chronic obstructive pulmonary disease (COPD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $7,165.98 and a completion date of March 6, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $7,270.10 and a period of performance that extends through October 20, 2023. The award is part of a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $7,214.80 and a period of performance through March 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,401.57, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm-fixed price delivery order, with a period of performance through March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,036.83, is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,611.35, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of April 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $3,757.27 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 60 units of the pharmaceutical product Trelegy Ellipta, which is used to treat chronic obstructive pulmonary disease (COPD). The order has a firm fixed price and an ultimate completion date of August 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...